Transcatheter Aortic Valve Implantation (TAVI) Market Share, Size, Growth Rate, and Forecast 2023-2028

According to IMARC Group's latest research report, titled "Transcatheter Aortic Valve Implantation (TAVI) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," offers a comprehensive analysis of the industry, which comprises insights on the transcatheter aortic valve implantation (TAVI) market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global transcatheter aortic valve implantation (TAVI) market size reached US$ 5.63 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.03 Billion by 2028, exhibiting a growth rate (CAGR) of 12.20% during 2023-2028.

Transcatheter Aortic Valve Implantation (TAVI) Market Overview:

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure for treating aortic valve stenosis. In this condition, the aortic valve becomes narrowed and restricts blood flow from the heart. TAVI is an alternative to open-heart surgery, particularly for high-risk or inoperable patients. A prosthetic valve is inserted through a catheter and guided to the heart through a blood vessel during the procedure. The new valve is then expanded, replacing the damaged or diseased valve. TAVI offers several advantages over traditional surgical valve replacement. It requires smaller incisions, reducing the risks associated with open-heart surgery, and leads to shorter hospital stays and quicker recovery times. It is also an option for patients who may not tolerate general anesthesia or have comorbidities that make surgery high-risk. While TAVI has been initially used for high-risk patients, technological advancements have expanded its use to intermediate and low-risk patients. The procedure continues to evolve, with ongoing research focusing on improving patient selection, optimizing valve designs, and refining procedural techniques.

Get Sample Copy of Report at – https://www.imarcgroup.com/transcatheter-aortic-valve-implantation-market/requestsample

Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The global market is primarily driven by the increasing prevalence of aortic valve diseases, particularly aortic stenosis. As the global population ages, the incidence of aortic valve diseases rises, creating a higher demand for effective treatment options such as TAVI. Furthermore, the technological advancements in TAVI procedures are significantly contributing to the market. Advances in TAVI technologies, such as the development of new valve designs, enhanced delivery systems, and imaging guidance, have improved procedural success rates, reduced complications, and expanded the eligible patient population.

These advancements are fueling the adoption of TAVI as a preferred treatment option, driving market expansion. Moreover, the growing elderly population is strengthening the market. With the aging global population, there is a higher number of patients requiring aortic valve interventions. TAVI offers a less invasive and safer option for elderly patients at higher surgical risk, making it an attractive treatment choice and driving the market. Additionally, the rising preference for minimally invasive treatment options is providing a boost to the market.

Key Market Segmentation:

Competitive Landscape with Key Players:

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• JC Medical Inc. (Genesis Medtech International Private Limited)
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.
• NVT AG (Biosensors International Group)
• Venus Medtech (Hangzhou) Inc.

Procedure Insights:

• Transfemoral Procedure
• Transapical Implantation
• Transaortic Implantation

End User Insights:

• Hospitals
• Diagnostic Labs
• Ambulatory Surgical Centers
• Clinics
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance 
• Market Outlook
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800